Erba Diagnostics (ERB) Tops Q2 EPS by 1c

Erba Diagnostics (NYSE: ERB) reported Q2 EPS of $0.01, $0.01 better than the analyst estimate of $0.00. Revenue for the quarter came in at $7.54 million versus the consensus estimate of $6.74 million.

For earnings history and earnings-related data on Erba Diagnostics (ERB) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Axos Financial (AX) PT Raised to $120 at Benchmark
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02